1AUA Practice Guidelines Committee.AUA guideline on management of benign prostatic hyperplasia (2003).Chapter 1:Diagnosis and treatment recommendations[J].J Urol,2003,170(2 Pt 1):530-547.
3Costa P,Ben Naoum K,Boukaram M,et al.Benign prostatic hyperplasia (BPH):prevalence in general practice and practical approach of French general practitioners.Results of a study based on 17,953 patients[J].Prog Urol,2004,14(1):33-39.
4Bauduceau B,Dupuy O.Atherosclerosis:butter on the arteries[J]?Rev Infirm,2005,109(1):16-20.
5Ghafar MA,Puchner PJ,Anastasiadis AG,Does the prostatic vascular system contribute to the development of benign prostatic hyperplasia[J]?Curr Urol Rep,2002,3(4):292-296.
6Berger AP,Deibl M,Halpern EJ.Vascular damage induced by type 2 diabetes mellitus as a risk factor for benign prostatic hyperplasia[J].Diabetologia,2005,48(4):784-489.
7Loran OB,Vishnevskii EL,Vishnevskii AE.The role of detrusor hypoxia in the pathogenesis of urination disorders in patients with benign prostatic hyperplasia[J].Urol Nefrol (Mosk),1996,(6):33-37.
8Cooper AL,Beasley D.Hypoxia stimulates proliferation and interleukin-1alpha production in human vascular smooth muscle cells[J].Am J Physiol,1999,277(4 Pt 2):H1326-1337.
9Riley DJ,Thakker-Varia S,Wilson FJ,et al.Role of proteolysis and apoptosis in regression of pulmonary vascular remodeling[J].Physiol Res,2000,49(5):577-585.
